Tricor, Fenofibrate News

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia SAN DIEGO-- --Santarus, Inc.

The Nurse Practitioner: The American Journal of Primary Health Care February 2012 Volume 37 Number 2 Pages 56 - 56 The FDA notified healthcare professionals that the cholesterol-lowering medication fenofibric acid may not lower a patient's risk of myocardial infarction or stroke.

As many new active pharmaceutical ingredients are poorly water soluble, solubility enhancers are one possibility to overcome the hurdles of drug dissolution and absorption in oral drug delivery.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

There is increasing interest in non-pharmacological control of cholesterol and triglyceride levels in the plasma and diet-drug association represent an important area of studies.